82 results
DEFA14A
EQ
Equillium Inc
11 Apr 24
Additional proxy soliciting materials
4:07pm
Additional Materials
Soliciting Material under § 240.14a-12
EQUILLIUM, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing … materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
P.O. BOX 8016, CARY, NC 27512-9903
8-K
EX-1.1
1ok 6gvjs5idy7ion3
5 Oct 23
Entry into a Material Definitive Agreement
5:28pm
424B5
rfw fnzuky3np0q0lnh
5 Oct 23
Prospectus supplement for primary offering
5:23pm
DEFA14A
qp9ggn1usgxgjhojl8
13 Apr 23
Additional proxy soliciting materials
4:03pm
PRE 14A
fwl7v5m el
31 Mar 23
Preliminary proxy
4:02pm
425
d7ss8tc4dnmnf1
14 Dec 22
Business combination disclosure
9:56pm
8-K
r4ks42
14 Dec 22
Other Events
9:49pm
425
ddmot10bu 48ke32m
6 Dec 22
Business combination disclosure
7:02am
8-K
EX-99.1
y7s7t
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
8-K
bd6lp0c1cm4q
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am